TransMedics Group, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
429.58 |
601.11 |
726.10 |
859.85 |
1,055.20 |
1,124.50 |
Przychód Δ r/r |
0.00% |
39.93% |
20.79% |
18.42% |
22.72% |
6.57% |
Przychód (min) |
428.46 |
593.96 |
693.62 |
853.40 |
1,023.34 |
1,090.55 |
Przychód (max) |
430.58 |
606.78 |
759.71 |
866.29 |
1,080.31 |
1,151.26 |
EBITDA (średnia) |
-179.22 |
-250.79 |
-302.93 |
-358.73 |
-440.23 |
-469.14 |
EBIT (średnia) |
-195.12 |
-273.03 |
-329.79 |
-390.54 |
-479.27 |
-510.75 |
EBIT % |
-45.42% |
-45.42% |
-45.42% |
-45.42% |
-45.42% |
-45.42% |
Zysk netto (średni) |
34.52 |
82.27 |
105.72 |
115.05 |
145.27 |
146.50 |
Zysk netto % |
8.03% |
13.69% |
14.56% |
13.38% |
13.77% |
13.03% |
EPS (średnia) |
0.98 |
2.34 |
2.73 |
3.59 |
4.12 |
4.16 |
Liczba analityków (Przychody) |
7 |
7 |
9 |
6 |
2 |
5 |
Liczba analityków (EPS) |
6 |
6 |
7 |
6 |
3 |
4 |
symbol |
TMDX |
TMDX |
TMDX |
TMDX |
TMDX |
TMDX |